ArticleACS omega2024
Enhancing Surgical Care: Development of Biocompatible, Superabsorbent Alternatives to Cotton Gauze Using Chia Mucilage and Poly(vinylpyrrolidone).
Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cotton gauze bandages have traditionally played a pivotal role in wound care and surgical procedures, absorbing fluids, including blood, and protecting against infection. However, their limited liquid absorption capacity raises concern about potential post-surgery complications if inadvertently retained. In response, resorbable and biocompatible polymers have emerged as a promising alternative to enhance surgical outcomes and mitigate inflammation. This study aims to develop a biocompatible, highly absorbent, and preferably resorbable substitute for cotton gauze, utilizing natural polysaccharides from chia seeds' mucilage alongside the synthetic polymer poly(vinylpyrrolidone) (PVP). Incorporating tranexamic acid, an antifibrinolytic agent, into the PVP solution enhances its efficacy in controlling blood flow. The polymer solution is then processed into nonwoven materials via solution blow spinning. UV-C radiation cross-linking is employed to bolster the nonwovens' performance and durability during liquid absorption and swelling. Results demonstrate that nonwoven samples comprising PVP and chia mucilage, cross-linked for 60 min with UV-C radiation, exhibit exceptional swelling capacity, absorbing approximately 3291% of their dry weight in saline solution. Microfiber analysis indicates alterations in fiber characteristics due to cross-linking duration. Cell viability tests affirm the biocompatibility of the produced materials. With their remarkable fluid absorption properties and potential for resorption, PVP/chia mucilage compositions supplemented with tranexamic acid offer a promising avenue for effectively managing surgical bleeding without adverse effects. Furthermore, these materials can safely remain within the surgical site, eventually undergoing natural resorption by the body owing to their resorbable nature.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.